The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
COSTAR GROUP INC COM 22160N109 55,493 153,007 SH   SOLE   153,007 0 0
LPL FINANCIAL HOLDINGS INC COM 50212V100 12,727 208,401 SH   SOLE   208,401 0 0
NANTKWEST INC COM 63016Q102 2,165 556,453 SH   SOLE   556,453 0 0
SORRENTO THERAPEUTICS INC COM NEW 83587F202 2,141 415,765 SH   SOLE   415,765 0 0
SABINE ROYALTY TRUST UNIT BEN INT 785688102 12,655 289,790 SH   SOLE   289,790 0 0
PLAYA HOTELS & RESORTS NV SHS N70544106 3,066 300,000 SH   SOLE   300,000 0 0
DAVE & BUSTER'S ENTERTAINMEN COM 238337109 5,009 120,000 SH   SOLE   120,000 0 0
APPFOLIO INC COM CL A 03783C100 2,344 57,372 SH   SOLE   57,372 0 0
EDITAS MEDICINE INC COM 28106W103 6,155 185,668 SH   SOLE   185,668 0 0
COUPA SOFTWARE INC COM 22266L106 488 10,704 SH   SOLE   10,704 0 0
SIENNA BIOPHARMACEUTICALS IN COM 82622H108 5,552 295,613 SH   SOLE   295,613 0 0
NANTHEALTH INC COM 630104107 361 118,503 SH   SOLE   118,503 0 0
UROGEN PHARMA LTD COM M96088105 5,515 110,989 SH   SOLE   110,989 0 0
UROGEN PHARMA LTD COM M96088105 3,514 70,713 SH   DFND   70,713 0 0
NANTHEALTH INC COM 630104107 250 81,870 SH   DFND   81,870 0 0
BARCLAYS BK PLC IPATH S&P500 VIX 06746L422 3,785 80,000 SH   DFND   80,000 0 0